[go: up one dir, main page]

EP2715359A4 - Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins - Google Patents

Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins

Info

Publication number
EP2715359A4
EP2715359A4 EP12792802.6A EP12792802A EP2715359A4 EP 2715359 A4 EP2715359 A4 EP 2715359A4 EP 12792802 A EP12792802 A EP 12792802A EP 2715359 A4 EP2715359 A4 EP 2715359A4
Authority
EP
European Patent Office
Prior art keywords
dosing
care
compositions
methods
point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12792802.6A
Other languages
German (de)
English (en)
Other versions
EP2715359A1 (fr
Inventor
Vuong Ngoc Trieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autotelic LLC
Original Assignee
STRING THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STRING THERAPEUTICS Inc filed Critical STRING THERAPEUTICS Inc
Publication of EP2715359A1 publication Critical patent/EP2715359A1/fr
Publication of EP2715359A4 publication Critical patent/EP2715359A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
EP12792802.6A 2011-05-30 2012-05-30 Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins Withdrawn EP2715359A4 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161491268P 2011-05-30 2011-05-30
US201161514488P 2011-08-03 2011-08-03
US201161526950P 2011-08-24 2011-08-24
US201161533250P 2011-09-11 2011-09-11
US201161577008P 2011-12-17 2011-12-17
US201261606371P 2012-03-03 2012-03-03
US201261615312P 2012-03-25 2012-03-25
US201261635730P 2012-04-19 2012-04-19
PCT/US2012/039993 WO2012166795A1 (fr) 2011-05-30 2012-05-30 Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins

Publications (2)

Publication Number Publication Date
EP2715359A1 EP2715359A1 (fr) 2014-04-09
EP2715359A4 true EP2715359A4 (fr) 2015-01-21

Family

ID=47259824

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12792802.6A Withdrawn EP2715359A4 (fr) 2011-05-30 2012-05-30 Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins

Country Status (6)

Country Link
EP (1) EP2715359A4 (fr)
JP (2) JP6184943B2 (fr)
CN (1) CN104160274A (fr)
AU (2) AU2012262322B2 (fr)
CA (1) CA2837331A1 (fr)
WO (1) WO2012166795A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135189L (fi) 2013-02-28 2014-08-29 iStoc Oy Kannettava lateraalinen koetulosten lukija
US20150154375A1 (en) * 2013-11-27 2015-06-04 Companion Dx Reference Lab, Llc. Systems and methods for optimizing drug therapies
JP2017513030A (ja) * 2014-04-04 2017-05-25 オートテリック エルエルシー パクリタキセルの薬物動態ガイド下投薬のための血漿中パクリタキセル濃度のモニタリングのための方法、デバイス、および試薬
US9714953B2 (en) 2014-04-04 2017-07-25 Autotelic Llc Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel
KR20160091348A (ko) * 2014-06-08 2016-08-02 오토텔릭 엘엘씨 부종없이 통증을 완화시키기 위한 고정된 용량의 복합제
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
WO2016057679A1 (fr) * 2014-10-09 2016-04-14 LuminaCare Solutions Inc. Plateforme de dosage personnalisé d'antibiotiques
CN107408147A (zh) * 2015-01-13 2017-11-28 奥托泰里克有限责任公司 用于个体化药物治疗的方法
WO2016115057A1 (fr) * 2015-01-13 2016-07-21 Autotelic Llc Association médicamenteuse à dose fixe destinée au soulagement de la douleur sans induire d'œdème
CN104899458B (zh) * 2015-06-16 2017-09-15 中国环境科学研究院 评价纳米金属氧化物健康效应的qsar毒性预测方法
TW201718656A (zh) 2015-10-07 2017-06-01 奧托德里克有限公司 用於結合紫杉醇之以抗體為主的親和性試劑
EP3384282A1 (fr) * 2015-11-30 2018-10-10 Pharnext Méthodes d'adaptation des doses des polythérapies
US9989543B2 (en) 2016-01-11 2018-06-05 Autotelic, Llc Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
EP3423831B1 (fr) 2016-03-02 2022-05-25 Waters Technologies Corporation Identification et détermination quantitative de peptides conjugués dans des conjugués anticorps-médicament par spectrométrie de masse
BR112018070463A8 (pt) 2016-04-15 2022-08-30 Baxalta GmbH Método e aparelho para prover um regime farmacocinético de dosagem de fármaco
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
CN108593828A (zh) * 2018-02-23 2018-09-28 李水军 血浆制备卡中药物和毒物含量的检测方法
WO2021041469A1 (fr) * 2019-08-26 2021-03-04 University Of Maryland, Baltimore Procédé et appareil d'administration individualisée de médicaments pour une administration à sécurité améliorée au sein d'une plage thérapeutique
WO2025059764A1 (fr) * 2023-09-18 2025-03-27 Appmed Inc. Système et procédé de surveillance et d'identification de l'efficacité de la posologie destinée à un individu

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (fr) * 2003-04-10 2004-10-28 Ivax Research, Inc. Compositions a base de taxane et procedes d'utilisation
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075174A (ja) * 1993-06-18 1995-01-10 Nippon Steel Corp 高検出能イムノアッセイ法
US6594168B2 (en) * 1997-05-30 2003-07-15 Micron Technology, Inc. 256 Meg dynamic random access memory
US6147095A (en) * 1998-11-04 2000-11-14 Pharmacia & Upjohn Company Method for improving the pharmacokinetics of tipranavir
AU4709400A (en) * 1999-05-11 2000-11-21 Ortho-Mcneil Pharmaceutical, Inc. Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
CN1615130A (zh) * 2001-12-28 2005-05-11 Ivax研究公司 基于紫杉烷的组合物及使用方法
EP1497647A1 (fr) * 2002-04-19 2005-01-19 Pfizer Products Inc. Test de mesure de niveaux de medicament therapeutique
CA2481567A1 (fr) * 2002-04-19 2003-10-30 International Business Machines Corporation Commande de puissance d'un processeur utilisant des structures materielles commandees par un compilateur a profil d'instructions accumulees
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
CA2554779A1 (fr) * 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions et procedes permettant de caracteriser, de reguler, de diagnostiquer et de traiter des cancers
US20060024768A1 (en) * 2004-07-29 2006-02-02 Saladax Biomedical, Inc. Taxol immunoassay
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
AU2006244617B2 (en) * 2005-05-09 2013-04-18 Labrador Diagnostics Llc Point-of-care fluidic systems and uses thereof
AU2006315760A1 (en) * 2005-11-10 2007-05-24 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Materials and methods for ABCB1 polymorphic variant screening, diagnosis, and treatment
BRPI0708392A2 (pt) * 2006-03-03 2011-05-24 Elan Pharm Inc métodos de tratamento de um paciente com uma doença inflamatória ou autoimune com natalizumab e de uso de natalizumab para tratar um paciente com uma doença inflamatória ou autoimune
US20070237719A1 (en) * 2006-03-30 2007-10-11 Jones Christopher M Method and system for monitoring and analyzing compliance with internal dosing regimen
JP5671523B2 (ja) * 2009-04-30 2015-02-18 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 濡れた多孔質材料を用いるイオン生成
BR112012000873A2 (pt) * 2009-07-17 2019-11-05 Myriad Genetics Inc método de dosar 5-fluorouracil em uma amostra de um paciente tratado com f-fu ou um pró-fármaco deste, método de tratar um paciente com 5-fluorouracil ou um pró-fármaco deste, método de processamento de uma amostra de sangue de um paciente tratado com um regime compreendendo 5-fluorouracil ou um pró-fármaco deste para um teste de 5-fluorouracil, método de processamento de uma amostra de sangue de um paciente tratado com um regime compreendendo 5-fluorouracil ou um pró-fármaco deste, composição, kit, kit de teste, conjunto de seringa de transferência

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (fr) * 2003-04-10 2004-10-28 Ivax Research, Inc. Compositions a base de taxane et procedes d'utilisation
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
F. K. ENGELS ET AL: "Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study", CLINICAL CANCER RESEARCH, vol. 17, no. 2, 11 January 2011 (2011-01-11), US, pages 353 - 362, XP055387687, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-10-1636 *
R. NAGESWARA RAO ET AL: "LC-ESI-MS/MS determination of paclitaxel on dried blood spots : LC-ESI-MS/MS determination of paclitaxel in dried blood spots", BIOMEDICAL CHROMATOGRAPHY., vol. 26, no. 5, 19 September 2011 (2011-09-19), GB, pages 616 - 621, XP055387688, ISSN: 0269-3879, DOI: 10.1002/bmc.1706 *
See also references of WO2012166795A1 *
STAN R SVOJANOVSKY ET AL: "High sensitivity ELISA determination of taxol in various human biological fluids", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 20, no. 3, 1 July 1999 (1999-07-01), US, pages 549 - 555, XP055387684, ISSN: 0731-7085, DOI: 10.1016/S0731-7085(99)00073-4 *

Also Published As

Publication number Publication date
JP2017207508A (ja) 2017-11-24
WO2012166795A1 (fr) 2012-12-06
EP2715359A1 (fr) 2014-04-09
CA2837331A1 (fr) 2012-12-06
AU2012262322A1 (en) 2014-01-23
CN104160274A (zh) 2014-11-19
JP6184943B2 (ja) 2017-08-23
AU2012262322B2 (en) 2016-11-03
AU2016277632A1 (en) 2017-01-19
JP2014518375A (ja) 2014-07-28

Similar Documents

Publication Publication Date Title
EP2715359A4 (fr) Procédés et compositions pour la surveillance et l'administration dosée d'un médicament thérapeutique par un profilage pharmaco-cinétique sur des lieux de soins
AP3864A (en) Pharmaceutical composition
SG11201401851UA (en) Methods for drug delivery
SI2776416T1 (sl) Farmacevtske spojine
EP2709645A4 (fr) Agents pharmaceutiques peptidiques améliorés
EP2756855A4 (fr) Dispositif d'injection de médicament
IL230861A (en) A rapidly dissolving pharmaceutical composition
GB201118232D0 (en) Pharmaceutical composition
EP2665431C0 (fr) Technologie d'administration de médicaments
GB2525835B (en) Pharmaceutical agent
ZA201308157B (en) Pharmaceutical composition
GB201119799D0 (en) Pharmaceutical compounds
EP2767257A4 (fr) Articulateur
ZA201403832B (en) Pharmaceutical compounds
GB201118876D0 (en) Pharmaceutical compounds
EP2731610A4 (fr) Combinaison pharmaceutique
GB201113163D0 (en) Pharmaceutical compounds
EP2727593A4 (fr) Composition pharmaceutique contenant du nicorandil
EP2711010A4 (fr) Composition pharmaceutique
EP2687212A4 (fr) Agent médicamenteux
PL2709599T3 (pl) Kompozycja farmaceutyczna zawierająca drotawerynę
HUP1100444A2 (en) Pharmaceutical composition
BR112013022907A2 (pt) composição farmacêutica
HUP1100445A2 (en) Pharmaceutical composition
PL2709470T3 (pl) System dozowania tytoniu

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20150105

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101ALI20141218BHEP

Ipc: G01N 33/543 20060101AFI20141218BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AUTOTELIC LLC

17Q First examination report despatched

Effective date: 20160712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180825